Compare ARQT & BANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARQT | BANF |
|---|---|---|
| Founded | 2016 | 1984 |
| Country | United States | United States |
| Employees | N/A | 2135 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.9B |
| IPO Year | 2020 | N/A |
| Metric | ARQT | BANF |
|---|---|---|
| Price | $24.58 | $108.15 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | $31.86 | ★ $129.50 |
| AVG Volume (30 Days) | ★ 1.2M | 88.2K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.80% |
| EPS Growth | ★ 88.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $376,072,000.00 | N/A |
| Revenue This Year | $34.46 | $6.10 |
| Revenue Next Year | $29.77 | $3.92 |
| P/E Ratio | ★ N/A | $16.38 |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $11.86 | $97.02 |
| 52 Week High | $31.77 | $138.15 |
| Indicator | ARQT | BANF |
|---|---|---|
| Relative Strength Index (RSI) | 43.36 | 40.11 |
| Support Level | $22.26 | $106.33 |
| Resistance Level | $27.65 | $115.92 |
| Average True Range (ATR) | 1.54 | 3.82 |
| MACD | -0.18 | -0.82 |
| Stochastic Oscillator | 29.08 | 25.60 |
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
BancFirst Corp is engaged in providing banking services. The company's business unit includes BancFirst metropolitan banks, BancFirst community banks, Pegasus Bank, Worthington, other financial services and executive, operations and support. BancFirst metropolitan banks, BancFirst community banks, Pegasus and Worthington offer traditional banking products such as commercial and retail lending and a full line of deposit accounts. Other financial services are specialty product business units including guaranteed small business lending, residential mortgage lending, trust services, securities brokerage, electronic banking, and insurance.